Zhang Financial LLC Gilead Sciences, Inc. Transaction History

Zhang Financial LLC

$1.42 Billion
Q2 2024

A detailed history of Zhang Financial LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Zhang Financial LLC holds 11,635 shares of GILD stock, worth $984,204. This represents 0.06% of its overall portfolio holdings.

Number of Shares

11,635

Previous 15,211 23.51%

Holding current value

$984,204

Previous $1.11 Million 28.37%

% of portfolio

0.06%

Previous 0.08%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$63.15 - $72.88 $225,824 - $260,618	-3,576 Reduced 23.51%	11,635 $798,000
Q1 2024 Apr 24, 2024	BUY	$71.58 - $87.29 $129,345 - $157,733	1,807 Added 13.48%	15,211 $1.11 Million
Q4 2023 Jan 31, 2024	BUY	$73.27 - $83.09 $286,046 - $324,383	3,904 Added 41.09%	13,404 $1.09 Million
Q3 2023 Oct 11, 2023	SELL	$73.94 - $80.67 $389,515 - $424,969	-5,268 Reduced 35.67%	9,500 $711,000
Q2 2023 Jul 18, 2023	BUY	$76.01 - $86.7 $460,696 - $525,488	6,061 Added 69.61%	14,768 $1.14 Million
Q1 2023 May 10, 2023	BUY	$77.31 - $88.08 $231,543 - $263,799	2,995 Added 52.43%	8,707 $722,000
Q4 2022 May 17, 2023	SELL	$62.32 - $89.47 $186,648 - $267,962	-2,995 Reduced 34.4%	5,712 $490,000
Q4 2022 Jan 17, 2023	BUY	$62.32 - $89.47 $5,234 - $7,515	84 Added 1.49%	5,712 $490,000
Q3 2022 Oct 18, 2022	BUY	$59.54 - $68.01 $8,454 - $9,657	142 Added 2.59%	5,628 $347,000
Q2 2022 Jul 14, 2022	BUY	$57.72 - $65.01 $112,380 - $126,574	1,947 Added 55.02%	5,486 $339,000
Q1 2022 Apr 21, 2022	BUY	$57.92 - $72.58 $204,978 - $256,860	3,539 New	3,539 $210,000

Others Institutions Holding GILD

# of Institutions

1,880

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $106B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zhang Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zhang Financial LLC with notifications on news.

Account

Zhang Financial LLC Gilead Sciences, Inc. Transaction History